Navigation path

Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one

EU orphan designation number: EU/3/12/984   
Active ingredient: 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4 d]pyrimidin-1-yl]-1-piperidinyl]-2-propen-1-one
Indication: Treatment of chronic lymphocytic leukaemia
Sponsor: Janssen-Cilag International NV
Turnhoutseweg 30, B-2340 Beerse, BelgiŽ

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
30/04/2012 Centralised Orphan - Designation EMA/OD/156/11 (2012)2980 of 26/04/2012
18/01/2013 Centralised Orphan - Transfer of orphan designation EMA/OD/156/11/T/01 (2013)276 of 16/01/2013